Chen, Lisheng
Perera, N. Dayanthi
Karoukis, Athanasios J.
Feathers, Kecia L.
Ali, Robin R.
Thompson, Debra A.
Fahim, Abigail T.
Funding for this research was provided by:
National Eye Institute (P30EY007003)
Choroideremia Research Foundation
Eversight Vision
Research to Prevent Blindness
Article History
Received: 20 December 2021
Accepted: 14 July 2022
First Online: 26 July 2022
Competing interests
: ATF has equity in Ionis Pharmaceuticals and is a consultant for Janssen Pharmaceuticals. KLF, and DAT have research support from MeiraGTx. DAT has filed a patent on gene therapy. NDP, AJK, LC, and RRA have no competing interests to disclose.